JOHN MCLAUGHLIN Insider Trading $OCLS Sonoma Pharmaceuticals, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for JOHN MCLAUGHLIN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of JOHN MCLAUGHLIN. JOHN MCLAUGHLIN is Director in COMPUMED INC ($CMPD) and President and CEO in COMPUMED INC ($CMPD) and Director in Oculus Innovative Sciences, Inc. ($OCLS).
JOHN MCLAUGHLIN in Sonoma Pharmaceuticals, Inc.
Trading Symbol: OCLSIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of JOHN MCLAUGHLIN: Director
Holdings: 48,728 shares
Latest Transaction: Jun 01 2018
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of JOHN MCLAUGHLIN in Sonoma Pharmaceuticals, Inc.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 01 2018 | OCLS | Sonoma Pharmaceuti ... | MCLAUGHLIN JOHN | Director | Grant | A | 0.00 | 1,781 | 0 | 48,728 | 46.9 K to 48.7 K (+3.79 %) |
Mar 02 2018 | OCLS | Sonoma Pharmaceuti ... | MCLAUGHLIN JOHN | Director | Grant | A | 0.00 | 1,958 | 0 | 46,947 | 45 K to 46.9 K (+4.35 %) |
Jan 03 2018 | OCLS | Sonoma Pharmaceuti ... | MCLAUGHLIN JOHN | Director | Grant | A | 0.00 | 17,211 | 0 | 44,989 | 27.8 K to 45 K (+61.96 %) |
Dec 01 2017 | OCLS | Sonoma Pharmaceuti ... | MCLAUGHLIN JOHN | Director | Grant | A | 0.00 | 14,317 | 0 | 27,778 | 13.5 K to 27.8 K (+106.36 %) |
Aug 30 2017 | OCLS | Sonoma Pharmaceuti ... | MCLAUGHLIN JOHN | Director | Grant | A | 0.00 | 1,210 | 0 | 13,471 | 12.3 K to 13.5 K (+9.87 %) |
Jun 01 2017 | OCLS | Sonoma Pharmaceuti ... | MCLAUGHLIN JOHN | Director | Grant | A | 0.00 | 1,036 | 0 | 12,261 | 11.2 K to 12.3 K (+9.23 %) |
Mar 02 2017 | OCLS | Sonoma Pharmaceuti ... | MCLAUGHLIN JOHN | Director | Grant | A | 0.00 | 976 | 0 | 11,225 | 10.2 K to 11.2 K (+9.52 %) |
Mar 02 2017 | OCLS | Sonoma Pharmaceuti ... | MCLAUGHLIN JOHN | Director | Grant | A | 0.00 | 2,250 | 0 | 10,249 | 8 K to 10.2 K (+28.13 %) |
Nov 30 2016 | OCLS | Oculus Innovative ... | MCLAUGHLIN JOHN | Director | Grant | A | 0.00 | 1,423 | 0 | 7,999 | 6.6 K to 8 K (+21.64 %) |
Aug 30 2016 | OCLS | Oculus Innovative ... | MCLAUGHLIN JOHN | Director | Grant | A | 0.00 | 1,648 | 0 | 6,576 | 4.9 K to 6.6 K (+33.44 %) |
Jun 01 2016 | OCLS | Oculus Innovative ... | MCLAUGHLIN JOHN | Director | Grant | A | 0.00 | 6,765 | 0 | 24,643 | 17.9 K to 24.6 K (+37.84 %) |
Mar 02 2016 | OCLS | Oculus Innovative ... | MCLAUGHLIN JOHN | Director | Grant | A | 0.00 | 11,250 | 0 | 17,878 | 6.6 K to 17.9 K (+169.73 %) |
Mar 02 2016 | OCLS | Oculus Innovative ... | MCLAUGHLIN JOHN | Director | Grant | A | 0.00 | 6,628 | 0 | 6,628 | 0 to 6.6 K |
Dec 02 2015 | OCLS | Oculus Innovative ... | MCLAUGHLIN JOHN | Director | Option Exercise | A | 1.24 | 7,488 | 9,285 | 146,144 | |
Sep 02 2015 | OCLS | Oculus Innovative ... | MCLAUGHLIN JOHN | Director | Option Exercise | A | 1.21 | 7,774 | 9,407 | 138,656 | |
Jun 02 2015 | OCLS | Oculus Innovative ... | MCLAUGHLIN JOHN | Director | Option Exercise | A | 0.90 | 10,610 | 9,549 | 130,882 | |
Mar 03 2015 | OCLS | Oculus Innovative ... | MCLAUGHLIN JOHN | Director | Option Exercise | A | 0.86 | 11,026 | 9,482 | 120,272 |
Page: 1